5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.73▼ | 9.69▼ | 9.64▲ | 9.61▲ | 9.31▲ |
MA10 | 9.74▼ | 9.64▲ | 9.62▲ | 9.40▲ | 9.56▲ |
MA20 | 9.72▼ | 9.63▲ | 9.62▲ | 9.16▲ | 10.59▼ |
MA50 | 9.64▲ | 9.61▲ | 9.49▲ | 9.58▲ | 14.89▼ |
MA100 | 9.63▲ | 9.46▲ | 9.24▲ | 10.67▼ | 14.73▼ |
MA200 | 9.63▲ | 9.21▲ | 9.40▲ | 13.77▼ | 11.64▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | 0.010▲ | -0.001▼ | 0.114▲ | 0.157▲ |
RSI | 46.501▼ | 55.512▲ | 56.333▲ | 54.292▲ | 38.284▼ |
STOCH | 61.478 | 65.935 | 59.127 | 89.459▲ | 38.134 |
WILL %R | -94.118▼ | -32.653 | -26.667 | -6.036▲ | -65.152 |
CCI | -183.333▼ | 75.833 | 109.796▲ | 110.950▲ | -33.311 |
MA | $ASC Price Crossed Above MA(50) | Set Alert |
Tuesday, April 29, 2025 09:56 AM
"These are the first data to link ASC speck assembly ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
|
Tuesday, April 29, 2025 05:16 AM
Study supported by the Michael J. Fox Foundation through a grant awarded to ZyVersa and leading inflammasome experts at University of Miami Miller School of Medicine who conducted the ...
|
Tuesday, April 29, 2025 05:00 AM
ZyVersa's Inflammasome ASC Inhibitor IC 100 shows potential to ... April 29, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 9.61 | 9.77 | 9.53 | 9.70 | 534,000 |
30/04/25 | 9.57 | 9.70 | 9.445 | 9.54 | 418,648 |
29/04/25 | 9.585 | 9.73 | 9.56 | 9.66 | 267,086 |
28/04/25 | 9.53 | 9.68 | 9.4516 | 9.55 | 393,207 |
25/04/25 | 9.36 | 9.675 | 9.27 | 9.58 | 368,225 |
24/04/25 | 9.31 | 9.42 | 9.09 | 9.37 | 381,190 |
23/04/25 | 9.12 | 9.29 | 8.885 | 9.26 | 405,507 |
22/04/25 | 9.20 | 9.23 | 8.9301 | 9.01 | 372,296 |
21/04/25 | 9.10 | 9.19 | 9.0119 | 9.11 | 361,430 |
17/04/25 | 8.88 | 9.28 | 8.86 | 9.22 | 481,548 |
|
|
||||
|
|
||||
|
|